New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
18:40 EDTLGF, BNNY, RTRX, VEEV, EXPR, BLOX, NMBL, OVTI, GLUU, SPLK, CRM, AVGOOn The Fly: After Hours Movers
UP AFTER EARNINGS: OmniVision (OVTI), up 17.9% after reporting better than expected fourth quarter results and first quarter guidance above expectations... Veeva Systems (VEEV), up 6.2%... Avago (AVGO), up 1.5% after reporting quarterly results... Nimble Storage (NMBL), up 3.76%... ALSO HIGHER: Retrophin (RTRX), up 29.27% following license agreement with Mission Pharmacal for Thiola and revised guidance... salesforce.com (CRM), up 1.75% after announcing global strategic partnership with Microsoft (MSFT). DOWN AFTER EARNINGS: Infoblox (BLOX), down 28.12% after guiding below analyst estimates for fourth quarter and announcing that CEO Robert Thomas is stepping down... Annies (BNNY), down 16.86%... Splunk (SPLK), down 9.15%... Express (EXPR), down 10.27% after reporting quarterly results and announcing that it will close 50 stores over the next 36 months... Lions Gate (LGF), down 5.99%. ALSO LOWER: Glu Mobile (GLUU), down 7.4%.
News For OVTI;VEEV;AVGO;NMBL;RTRX;CRM;BLOX;BNNY;SPLK;EXPR;LGF;GLUU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 18, 2015
10:15 EDTRTRXRetrophin moves off earlier highs, levels to watch
Subscribe for More Information
09:23 EDTRTRXOn The Fly: Pre-market Movers
Subscribe for More Information
07:48 EDTRTRXRetrophin to acquire worldwide rights to Cholbam after FDA approval
Retrophin announced that the FDA has approved Cholbam capsules, the first FDA approved treatment for pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, and for patients with peroxisomal disorders, including Zellweger spectrum disorders. As a result of the approval, Retrophin will exercise its right to purchase from Asklepion Pharmaceuticals all worldwide rights, titles, and ownership of Cholbam and related assets. Under the terms of the agreement announced on January 12, Retrophin will pay Asklepion a one-time cash payment of $27M, in addition to approximately 661,278 shares of Retrophin common stock, initially valued at $9M at the time of the agreement, which assumes Cholbam received an approval for a CTX indication. Asklepion will also be eligible to receive up to $37M in cumulative sales milestones, as well as tiered royalties based on future net sales of Cholbam. The FDA also granted Asklepion a Rare Pediatric Disease Priority Review Voucher, a provision that encourages development of new drugs and biologics for the prevention and treatment of rare pediatric diseases. This voucher is designed to be transferable or sold and provides the bearer with an expedited FDA review for any new drug application. The Pediatric PRV will be transferred to Retrophin under the original terms of the agreement with Asklepion. Cholbam will have seven years market exclusivity in the U.S. conferred by its designation as an orphan drug. Retrophin expects to close the acquisition and be able to begin distributing therapy in as few as two to four weeks, subject to the satisfaction of customary closing conditions.
06:53 EDTLGFLionsgate closing $375M financing agreement with Chinese broadcaster, WSJ says
Lionsgate CEO Jon Feltheimer said in a Wall Street Journal interview that the company is closing a $375M financing agreement with Hunan TV & Broadcast Intermediary that may boost its ability to screen films in China. Hunan will fund 25% of Lionsgate production costs over a three year period which the Journal notes could total $1.5B, though popular franchises "Hunger Games," "Divergent," and "Twilight" are not covered. Hunan's subsidiary will acquire rights to distribute up to four Lionsgate films in China, and the two companies will also produce films and television shows for both U.S. and Chinese markets, with a "Candy Crush Saga" TV show being a likely first candidate, according to Feltheimer. Reference Link
March 17, 2015
17:30 EDTCRMOracle says will outsell Salesforce.com in new SaaS, PaaS business this year
Subscribe for More Information
17:24 EDTCRMOracle says growing faster than Salesforce.com
Subscribe for More Information
10:13 EDTEXPROptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTCRMOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Aimco (AIV) initiated with an Outperform at RW Baird... Alnylam (ALNY) initiated with a Buy at Janney Capital... American Campus (ACC) initiated with a Neutral at RW Baird... AvalonBay (AVB) initiated with a Neutral at RW Baird... BE Aerospace (BEAV) initiated with a Buy at CRT Capital... BlackRock (BLK) initiated with a Buy at Argus... Camden Property (CPT) initiated with an Outperform at RW Baird... CarMax (KMX) initiated with a Buy at Evercore ISI... Central Pacific (CPF) initiated with a Neutral at Macquarie... Cognex (CGNX) initiated with a Buy at Northcoast... Education Realty (EDR) initiated with a Neutral at RW Baird... EnerSys (ENS) initiated with an Overweight at Stephens... Equity Lifestyle (ELS) initiated with an Outperform at RW Baird... Equity Residential (EQR) initiated with a Neutral at RW Baird... Essex Property Trust (ESS) initiated with a Neutral at RW Baird... Facebook (FB) initiated with a Buy at Brean Capital... Intercept (ICPT) initiated with a Hold at MLV & Co.... Isis Pharmaceuticals (ISIS) initiated with a Neutral at Janney Capital... LinkedIn (LNKD) initiated with a Sell at Brean Capital... Mid-America Apartment (MAA) initiated with an Outperform at RW Baird... NetSuite (N) initiated with a Hold at Brean Capital... Paycom (PAYC) initiated with a Buy at Brean Capital... Platform Specialty Products (PAH) initiated with a Buy at UBS... Post Properties (PPS) initiated with a Neutral at RW Baird... Salesforce.com (CRM) initiated with a Hold at Brean Capital... ServiceNow (NOW) initiated with a Buy at Brean Capital... Snap-On (SNA) initiated with a Buy at Northcoast... Sun Communities (SUI) initiated with a Neutral at RW Baird... Twitter (TWTR) initiated with a Buy at Brean Capital... UDR, Inc. (UDR) initiated with an Outperform at RW Baird... Workday (WDAY) initiated with a Hold at Brean Capital... Xplore Technologies (XPLR) initiated with a Buy at Roth Capital... Yahoo (YHOO) initiated with a Hold at Argus.
09:25 EDTGLUUOn The Fly: Pre-market Movers
Subscribe for More Information
08:41 EDTGLUUGlu Mobile to partner with Kendall, Kylie Jenner on new mobile game
Glu Mobile announced that the company will partner with Kendall and Kylie Jenner on the development of a new mobile game. Featuring the voices, likenesses, and creative influences of Kendall and Kylie, the game will allow players to interact with the sisters as friends and mentors as they work to realize their creative and career aspirations. Glu expects to launch the game worldwide in late 2015 on iOS and Android. Glu will provide additional details on the game's development and Kendall and Kylie's involvement at a later date. Shares of Glu Mobile, the maker of "Kim Kardashian: Hollywood," are up about 7% in pre-market trading to $5.15.
07:07 EDTVEEVVeeva says selected by GlaxoSmithKline for multichannel CRM
Subscribe for More Information
07:06 EDTVEEVVeeva selected by GSK as global multichannel CRM partner
Subscribe for More Information
March 16, 2015
16:26 EDTCRMSalesforce.com initiated with a Hold at Brean Capital
Target $70.
16:21 EDTRTRXRetrophin files to sell 5.1M shares of common stock
Subscribe for More Information
11:08 EDTNMBLNimble Storage management to meet with Needham
Subscribe for More Information
11:03 EDTAVGOAvago ships over 1M VCSEL channels
Subscribe for More Information
11:00 EDTSPLKArrow Electronics and Splunk announce distribution agreement
Subscribe for More Information
10:14 EDTEXPROptions with decreasing implied volatility
Options with decreasing implied volatility: EXPR ULTA SGMS QIHU BKS PAY URBN AGN AGNC
10:02 EDTAVGOOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AmerisourceBergen (ABC) upgraded to Buy from Neutral at UBS... Avago (AVGO) upgraded to Buy from Neutral at DA Davidson... Francesca's (FRAN) upgraded to Buy at Janney Capital... Goldcorp (GG) upgraded to Overweight from Neutral at HSBC... Jabil Circuit (JBL) upgraded to Buy from Hold at Cross Research... JetBlue (JBLU) upgraded to Outperform at Raymond James... King Digital (KING) upgraded to Overweight from Neutral at JPMorgan... L.B. Foster (FSTR) upgraded to Outperform from Neutral at Macquarie... NextEra Energy (NEE) upgraded to Buy from Hold at Deutsche Bank... Petrobras Argentina (PZE) upgraded to Buy from Neutral at BofA/Merrill... Qorvo (QRVO) upgraded to Buy from Neutral at DA Davidson... Randgold (GOLD) upgraded to Overweight from Neutral at HSBC... Royal Gold (RGLD) upgraded to Overweight from Neutral at HSBC... Seagate (STX) upgraded at Needham... Standex (SXI) upgraded to Buy from Hold at BB&T... Union Pacific (UNP) upgraded to Outperform from Neutral at Macquarie... West Corp. (WSTC) upgraded to Outperform from Neutral at RW Baird... Xilinx (XLNX) upgraded to Buy from Hold at Drexel Hamilton... YPF (YPF) upgraded to Buy from Neutral at BofA/Merrill.
07:57 EDTAVGOAvago upgraded to Buy from Neutral at DA Davidson
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use